ArticleThe American journal of case reports2025
Selective IgA Deficiency Complicated with Pernicious Anemia Diagnosed After Febrile Non-Hemolytic Transfusion Reaction.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Selective immunoglobulin A deficiency (SIgAD) is the most common primary immunodeficiency. However, most people with SIgAD are asymptomatic, and it is typically diagnosed during screening for blood donations or unexpected transfusion reactions. Screening programs for IgA deficiency have not yet been established, and the exact etiology of IgA deficiency remains unclear. CASE REPORT We report a case of SIgAD in a man who was diagnosed after a febrile non-hemolytic transfusion reaction (FNHTR) during erythrocyte transfusion for severe anemia. A 70-year-old man with a history of surgery for gastric carcinoid and sigmoid colon cancer presented to our hospital with persistent fatigue and general malaise for 2 months. A blood test revealed severe anemia with hyperbilirubinemia at the first visit to our hospital, and an erythrocyte transfusion was performed. A fever of 39.4°C with shivering was observed 30 min after the start of the transfusion. On day 20 after discharge, the serum IgA level was <3 µg/dL, indicating a high probability of IgA deficiency. He also tested positive for serum anti-IgA antibodies, leading to a diagnosis of SIgAD. CONCLUSIONS The cause of transfusion reaction should be immediately investigated, and the physician needs to learn about the epidemiology of transfusion reaction. Once the cause of transfusion reaction is identified, appropriate instruction should be provided for the patient to avoid transfusion reactions, and patients with SIgAD may benefit from wearing a medical alert bracelet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.